Pring, E. J.; Clare, S.; Hare, R.; Sheppard, S.; Marsden, M.; INTREPID consortium, ; Clement, M.; Chapman, L.; Harcourt, K.; Ballesteros Reviriego, C.; Brandt, C.; Andres, A.; Abu-Helil, B.; Iyer, V.; van der Weyden, L.; Oliver, M. A.; Lyons, P. A.; Wang, E. C.; Adams, D. J.; Cook, M. C.; Davis, D. M.; Humphreys, I. R.; Speak, A. O.

Natural killer (NK) cells are critical innate immune effectors in antiviral and antitumour responses. However, the factors governing NK cell development and function remain incompletely understood. To address this, we adopted an in vivo screening approach, generating a panel of mice deficient in genes differentially expressed across NK cell maturation stages or following viral infection. We performed a combinational screen comprising baseline immunophenotyping and mouse cytomegalovirus (MCMV) challenge. We identified novel regulators of NK cell development, including transcriptional regulators and proteins with putative trafficking functions. MCMV challenge studies additionally identified proteins that impacted antiviral immunity independently of NK cell phenotypes, including a novel regulator of NK cell degranulation, Synaptotagmin-like protein 3. Identified genes exhibited reduced tolerance to loss-of-function in large scale human sequencing studies and evidence for reduced NK cell numbers in a cohort of immunodeficiency patients. Together, these findings provide a resource of NK-expressed genes important for NK cell maturation and function, with relevance to human health.